ILMN vs KURA · rev $4.34B vs rev $20.9M
Illumina Inc (ILMN) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
ILMN currently screens at market cap $15.84B. KURA currently screens at market cap $861.1M.
Not investment advice. Open the ILMN and KURA stock pages for the full models.
Not investment advice.